A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

NCT07686679 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-08-10

No results posted yet for this study

Summary

This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia

Conditions

  • Functional Dyspepsia

Interventions

DRUG

DA-9701

1 tablet, TID

DRUG

DA-9701-R

1 tablet, TID

DRUG

DA-9701 Placebo

1 tablet, TID

DRUG

DA-9701-R Placebo

1 tablet, TID

Sponsors & Collaborators

  • Dong-A ST Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-06
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07686679 on ClinicalTrials.gov